Pathstone Family Office, LLC Astrazeneca PLC Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pathstone Family Office, LLC holds 64,744 shares of AZN stock, worth $4.97 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

64,744

Previous 49,780 30.06%

Holding current value

$4.97 Million

Previous $3.56 Million 23.08%

% of portfolio

0.03%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $970,415 - $1.07 Million	14,964 Added 30.06%	64,744 $4.38 Million
Q2 2023 Jan 12, 2024	SELL	$69.91 - $75.81 $1.05 Million - $1.13 Million	-14,964 Reduced 23.11%	49,780 $3.56 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $229,584 - $248,960	-3,284 Reduced 6.19%	49,780 $3.56 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $493,138 - $559,124	-7,809 Reduced 12.83%	53,064 $3.68 Million
Q4 2022 Oct 23, 2023	BUY	$54.21 - $70.44 $1.02 Million - $1.33 Million	18,900 Added 45.03%	60,873 $4.13 Million

Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $532,071 - $691,368	9,815 Added 19.22%	60,873 $4.13 Million
Q3 2022 Oct 23, 2023	BUY	$53.02 - $135.75 $891,266 - $2.28 Million	16,810 Added 66.8%	41,973 $2.3 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $863,907 - $2.21 Million	16,294 Added 46.87%	51,058 $2.81 Million
Q2 2022 Oct 23, 2023	SELL	$59.26 - $71.14 $1.46 Million - $1.75 Million	-24,617 Reduced 49.45%	25,163 $1.66 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $760,779 - $913,295	12,838 Added 58.55%	34,764 $2.3 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $22,288 - $26,848	-400 Reduced 1.79%	21,926 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $87,782 - $103,723	1,625 Added 7.85%	22,326 $1.3 Million
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $251,909 - $275,621	4,534 Added 28.04%	20,701 $1.24 Million
Q2 2021 Aug 31, 2021	BUY	$48.42 - $60.18 $206,656 - $256,848	4,268 Added 35.87%	16,167 $968,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $443,539 - $512,008	9,405 Added 377.11%	11,899 $592,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $96,263 - $115,111	1,984 Added 389.02%	2,494 $125,000
Q1 2020 Jun 11, 2020	BUY	$37.79 - $51.33 $19,272 - $26,178	510 New	510 $23,000
Q1 2020 May 07, 2020	SELL	$37.79 - $51.33 $47,577 - $64,624	-1,259 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $31,802 - $37,794	749 Added 146.86%	1,259 $627,000
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $18,099 - $21,940	510 New	510 $21,000

Others Institutions Holding AZN

# of Institutions

1,248

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $238B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Astrazeneca PLC Transaction History